Related Experiment Video
Updated: Apr 3, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.4K
Personalized Medicine: Monogenic Diabetes
The Journal of the Arkansas Medical Society
|September 23, 2015
Summary
Personalized medicine for diabetes is advancing, with genetics potentially guiding treatment. Monogenic diabetes, a single-gene form, offers a model for tailoring care to individual patients.
Area of Science:
- Endocrinology
- Genetics
- Pharmacology
Background:
- Diabetes prevalence and treatment options are rapidly increasing.
- Personalized, patient-centered care is now a cornerstone of diabetes management.
- The role of genetics in optimizing diabetes therapy is an emerging area of research.
Purpose of the Study:
- To review the current landscape of personalized medicine in diabetes.
- To explore the potential of pharmacogenetics in guiding diabetes treatment.
- To discuss the diagnosis and management of monogenic diabetes.
Main Methods:
- Literature review of recent studies in personalized diabetes care.
- Analysis of pharmacogenetic research on metformin and GLP-1 therapies.
- Examination of diagnostic and therapeutic approaches for monogenic diabetes.
Main Results:
- Pharmacogenetic variations influence patient response to certain diabetes medications.
- Monogenic diabetes, though rare, serves as a valuable model for personalized treatment strategies.
- Genetics may help predict individual responses to specific diabetes agents.
Conclusions:
- Personalized medicine holds promise for improving diabetes management.
- Pharmacogenetics can potentially guide the selection of diabetes therapies.
- Understanding monogenic diabetes is key to advancing individualized care approaches.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
01:22Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
01:22Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:50Combination Therapies and Personalized Medicine
1.8K
1.8K
01:20Pathophysiology of Diabetes
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K